Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT01416389 2019-09-18

A Study of LY2523355 in Participants With Breast Cancer

Phase 2 Completed

39 enrolled 16 charts

Breast

Breast Neoplasms, Neoplasms, Recurrence

NCT03559387 2019-02-12

Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia

Phase 2 Terminated

9 enrolled

Chemotherapy-induced Neutropenia

NCT00094809 2018-10-17

Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer

Phase 2 Completed

252 enrolled 19 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01648322 2018-10-03

Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 2 Completed

232 enrolled 19 charts

Breast

Breast Neoplasms, Neutropenia

NCT01712009 2018-01-30

NOLAN

Phase 2 Completed

600 enrolled 15 charts

Breast

Breast Neoplasms

NCT00364468 2017-03-03

Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

Phase 2 Completed

107 enrolled

Lymphoid

Lymphoma, Neutropenia

NCT00115193 2013-08-29

Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma

Phase 2 Completed

77 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Neoplasms, Neutropenia

NCT00035620 2010-02-26

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

Phase 2 Completed

44 enrolled

Sarcoma

Bone Neoplasms, Neutropenia, Sarcoma

NCT00124111 2010-02-26

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Phase 2 Completed

Breast

Breast Neoplasms, Neoplasms, Neutropenia

NCT00261313 2010-02-26

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

Phase 2 Completed

80 enrolled

Breast

Breast Neoplasms

NCT00117897 2009-07-20

Treatment for Subjects With Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoid

Lymphoma, Non-Hodgkin, Neutropenia

NCT00114764 2008-10-31

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

Phase 2 Completed

84 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Neutropenia, Leukemia, Myeloid, Acute

NCT00115414 2008-08-01

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

Phase 2 Completed

Breast

Breast Neoplasms, Fever, Neutropenia

NCT00117455 2008-05-16

A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoid

Lymphoma, Non-Hodgkin

NCT00066092 2008-02-28

Pegfilgrastim PBPC Mobilization Study

Phase 2 Completed

41 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms

Clinical Trials

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2

Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer

A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

Plinabulin iv Solution in Prevention of TAC Induced Neutropenia

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

A Study of LY2523355 in Participants With Breast Cancer

Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia

Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer

Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

NOLAN

Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

Treatment for Subjects With Non-Hodgkin's Lymphoma

Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma

Pegfilgrastim PBPC Mobilization Study